Comprehensive B2B guide and direct manufacturing specification for ISO-certified Blood Transfusion Sets. Engineered for micro-clot retention, hemolysis prevention, and precise drop-rate regulation in hospital blood banking and critical care.
Engineered with 200-micron nylon mesh filters and hemocompatible polymers to eliminate micro-clots while preventing mechanical hemolysis of red blood cells.
Precision plastic injection moulding, medical extrusion, and high-frequency welding inside ISO Class 7 cleanrooms with automated optical inspection.
Supplying government tenders, hospital procurement networks, and pharmaceutical private labels in over 52 countries across 6 continents since 1994.
Understanding the engineering nuances, material science parameters, and quality assurance checkpoints essential for tender evaluation and hospital safety.
In global healthcare procurement, the Blood Transfusion Set (also referred to as a blood administration set) represents a safety-critical clinical disposable. Unlike standard IV infusion lines designed solely for crystalloid or colloid electrolyte solutions, a blood administration set must transport complex biological cellular suspensions—including Whole Blood, Packed Red Blood Cells (PRBCs), Platelets, and Fresh Frozen Plasma (FFP)—without compromising cellular membrane integrity or introducing pyrogenic micro-particulates into the patient's vascular system.
The operational environment of modern hematology and surgical intensive care units demands strict alignment with international quality frameworks, specifically ISO 1135-4 (Transfusion equipment for medical use — Part 4: Transfusion sets for single use, gravity feed). Procurement officers, biomedical engineers, and institutional distributors must analyze key technical variables including filter surface area pore size distribution, plasticizer elution profiles, drip orifice calibration, and tensile burst thresholds of bonded joints.
At Angiplast Pvt. Ltd., our manufacturing methodology incorporates 30+ years of dedicated polymer processing experience. Operating from our state-of-the-art facility in Kheda, near Ahmedabad (Gujarat, India), we synthesize raw medical-grade PVC, ABS, and Polypropylene into high-performance transfusion systems. This guide provides actionable technical information gain for procurement officers, hospital tender boards, and OEM partners evaluating high-volume transfusion set contracts.
Class 10,000 Cleanroom Certified Why do standard 15-micron IV fluid filters fail in blood transfusion workflows? Standard IV fluid filters possess microscopic pore geometries (15–20 µm) intended to trap fine chemical particulates. When red blood cells (averaging 7–8 µm in diameter with flexible biconcave geometries) pass through a 15-micron filter under pressure, high shear forces cause mechanical erythrocyte rupture (hemolysis), releasing free hemoglobin and intracellular potassium into the bloodstream. This can trigger acute renal failure, hyperkalemia, and transfusion reactions.
In contrast, an ISO 1135-4 compliant Blood Transfusion Set utilizes a precision-woven nylon or polyester mesh filter with a standardized pore size of 170 to 200 microns. This specific spatial matrix effectively traps aggregated micro-clots, white blood cell debris, and donor fibrin strands while allowing unhindered passage of intact erythrocytes and platelets under gravity or low-pressure infusion. Angiplast’s drip chambers maintain an internal fluid contact surface engineered to minimize surface tension turbulence, guaranteeing zero mechanical hemolysis during extended transfusions.
Select from our standard catalogue variants or request customized OEM/ODM configurations tailored to institutional tender requirements.
Features a sharp, rigid ABS piercer (spike) integrated with a hydrophobic air inlet filter (0.2 µm filter membrane) and protective cap. Designed for blood bags and glass bottle containers requiring pressure equalization.
Engineered specifically for collapsible plastic blood collection bags (such as CPDA-1 triple/quadruple blood bag systems). Eliminates external air contact to maintain absolute closed-system sterility during gravity transfusion.
Designed for sensitive patient demographics including neonates, pediatric oncology, and long-term dialysis patients. Eliminates Di(2-ethylhexyl)phthalate (DEHP) leaching into lipophilic blood components.
Incorporates an advanced swappable needle-free valve port (split-septum or mechanical valve design) to prevent accidental needle-stick injuries and reduce Nosocomial Catheter-Related Bloodstream Infections (CRBSI).
Equipped with a 100 ml or 150 ml graduated burette chamber for precise volume-restricted pediatric blood transfusions. Includes auto shut-off float valve to prevent air entrainment upon chamber depletion.
Constructed with reinforced thick-wall flexible tubing (1.2 mm wall thickness) designed to withstand external pressure infusers (up to 300 mmHg pressure bags) during emergency trauma care and intraoperative hemorrhages.
| Technical Parameter | ISO 1135-4 Benchmark Specification | Angiplast Manufacturing Standard | Procurement Benefit |
|---|---|---|---|
| Filter Pore Size | 170 µm to 200 µm mesh pore size | Monofilament Nylon 200 µm (± 5 µm precision) | Prevents micro-clot embolization while eliminating RBC hemolysis. |
| Filtration Area | Minimum 10 cm² effective area | Enhanced 16 cm² to 20 cm² pleated surface area | Prevents premature filter clogging during multi-unit blood transfusions. |
| Drop Factor Calibration | 20 drops/ml ± 10% (using distilled water) | 20 drops/ml (0.1g ± 0.05g drop weight control) | Ensures accurate drip-rate calculation for gravity-feed infusions. |
| Tubing Elasticity & Kink Resistance | Shore A Hardness 72 to 78 | Shore A 75 Virgin Medical-Grade PVC / TOTM | Restores lumen cross-section immediately after roller clamp occlusion. |
| Tensile Strength of Joints | ≥ 15 N pull force for 15 seconds | ≥ 25 N solvent bonded & ultrasonic weld joint integrity | Eliminates catastrophic disconnections during emergency rapid infusions. |
| Endotoxin Limit (LAL Test) | < 0.5 EU/ml (Non-pyrogenic) | < 0.25 EU/ml batch certified release threshold | Exceeds United States Pharmacopeia (USP <85>) pyrogen guidelines. |
| Ethylene Oxide Residue | ≤ 4.0 mg/device (ISO 10993-7 compliance) | ≤ 1.2 ppm residual after extended aeration cycles | Guarantees zero chemical tissue irritation or patient systemic toxicity. |
How shifting regulatory standards, material safety mandates, and clinical safety innovations are reshaping global blood administration set tenders.
The global medical disposables industry is undergoing a structural transition driven by the European Union Medical Device Regulation (EU MDR 2017/745) Annex I, Section 10.4. Plasticizers such as Di(2-ethylhexyl)phthalate (DEHP) are classified as Substances of Very High Concern (SVHC) due to potential endocrine-disrupting properties. During blood storage and transfusion, lipid-rich blood components dissolve DEHP from standard PVC tubing walls, causing gradual plasticizer elution into the patient stream.
Over the 2025–2030 decade, institutional tenders in Europe, North America, and progressive healthcare systems in LatAm and Asia are mandating DEHP-Free Blood Transfusion Sets. Manufacturers are adopting alternative plasticizers like Trioctyl Trimellitate (TOTM), Hexamoll® DINCH, or bio-based epoxidized soybean oil (ESO) formulations. Angiplast’s polymer R&D division has perfected TOTM-PVC and Thermoplastic Elastomer (TPE) extrusion processes, offering tender-ready phthalate-free blood lines that maintain crystal-clear transparency, identical shore hardness, and zero leachability risks.
Hospital-Acquired Infections (HAIs) and healthcare worker occupational needle-stick injuries remain primary cost drivers for hospital administrators. Modern infection control guidelines (CDC, WHO, and EU OSHA directives) strongly urge the elimination of open rubber injection sites (latex flashballs) on infusion and transfusion sets.
The industry trend is shifting rapidly toward integrated Swabable Needle-Free Y-Injection Valves. These closed-system valves feature flat swabable silicone surfaces that form a hermetic seal against micro-organisms. When combined with automated self-sealing Luer Lock mechanisms, they permit secondary medication flush (such as normal saline post-transfusion) without opening the primary circuit to ambient room air, reducing CRBSI incidence by over 40%.
Manual assembly of multi-component transfusion sets (comprising up to 12 distinct components: spike, cap, air vent, chamber, filter mesh, tubing, roller clamp, injection site, male luer, lock ring, needle, package) introduces risks of manual human error, micro-particulate contamination, and subtle joint solvent misalignment.
Leading manufacturers like Angiplast are transitioning to fully automated assembly lines integrated with high-speed CCD camera vision systems. Machine-vision inspection verifies 100% of manufactured units for key critical attributes: filter mesh weave integrity, ultrasonic weld perimeter continuity, solvent joint insertion depth, and drip orifice concentricity. This technology ensures zero-defect lot consistency for high-volume government healthcare tenders.
Automated Vision Inspection Enabled Vertical integration, captive sterilisation capabilities, and dedicated regulatory support make Angiplast the premier contract manufacturer for global healthcare brands.
Founded in 1994 in Ahmedabad, India, Angiplast Pvt. Ltd. has established itself as an ISO 13485 and CE-certified industry leader in single-use medical device production. With over 30 years of operational history, we specialize in high-volume contract development and manufacturing (CDMO/OEM) for global pharmaceutical corporations, hospital groups, and regional distributors.
Virtual Video Inspection: Angiplast Injection Moulding, Assembly, & ETO Sterilisation Infrastructure.
In-depth technical answers addressing regulatory compliance, material selection, OEM customization, and shipping logistics.
The critical structural and functional difference resides in the drip chamber filter mesh size and fluid contact dynamics. Standard IV infusion sets utilize a micro-liquid filter with a pore rating of 15 to 20 microns designed to trap micro-particulate matter from liquid medications and saline solutions. If blood is administered through a 15-micron IV set, red blood cells (RBCs) will rapidly clog the filter pore matrix, causing severe mechanical shear stress that ruptures cell membranes (hemolysis).
A specialized Blood Transfusion Set features an ISO 1135-4 compliant 200-micron nylon mesh filter inside an elongated flexible chamber. The 200-micron mesh efficiently entraps donor micro-thrombi, cellular debris, and fibrin strands accumulated during blood storage while permitting unharmed passage of red blood cells, leukocytes, and platelets.
Request Sample & Technical Catalog →ISO 1135-4 is the universally accepted international performance standard for single-use gravity-feed blood administration sets. Compliance validates that the device meets stringent benchmark metrics including: (1) Physical chamber design allowing rapid self-priming without air entrapment; (2) Drop orifice calibration delivering exactly 20 drops per milliliter of distilled water at 20°C; (3) Joint tensile connection strength of at least 15 Newtons; (4) Chemical limits on heavy metals (< 5 ppm) and reducing substances; and (5) Biological safety confirming non-hemolytic, non-pyrogenic, and non-cytotoxic properties per ISO 10993 standards.
Angiplast offers custom polymer formulations utilizing non-phthalate plasticizers such as Trioctyl Trimellitate (TOTM) or DINCH. In standard PVC formulations, DEHP is physically dissolved in the polymer matrix and can leach out when in prolonged contact with blood lipids. Our TOTM-formulated medical PVC tubing exhibits substantially higher molecular weight stability, reducing plasticizer elution to non-detectable laboratory levels under ISO 10993-18 chemical characterization testing. This ensures full compliance with European MDR regulations and international neonatal safety guidelines.
Every manufacturing lot of Angiplast Blood Transfusion Sets undergoes comprehensive 5-stage quality validation prior to release certificate issuance:
Yes. As a primary CDMO/OEM contract manufacturer, we offer full custom engineering. B2B clients can specify: (1) Tubing length from 150 cm up to 220 cm; (2) Vented or Non-Vented spikes; (3) Drip chamber sizes (standard 10 ml or extended 15–20 ml); (4) Injection site options (latex flashball, latex-free Y-site, or needle-free swabable valve); (5) Luer lock design (fixed male luer or rotating lock ring collar); and (6) Integrated vein needles ranging from 18G to 21G with thin-wall ultra-sharp bevels.
Discuss OEM/Private Label Requirements →Angiplast’s dedicated regulatory affairs department provides comprehensive dossier packages for importer registration, including: Device Master Files (DMF), Technical Files compliant with STED format, ISO 13485 QMS certificates, CE Certificates of Conformity, Free Sale Certificates (FSC) legalized by Chamber of Commerce and relevant embassies, ISO 10993 Biocompatibility test reports, ETO sterilisation validation reports (ISO 11135), Accelerated 5-Year Shelf-Life Stability Study data, and multi-lingual Instructions for Use (IFU).
For standard Angiplast brand ("Angel Touch") packaging, our standard MOQ is typically 10,000 units per SKU. For custom OEM private-label branding, customized pouch artwork, and specific component configurations, the standard MOQ starts at 50,000 units (equivalent to one 20ft container load). Standard lead times range from 20 to 30 days post artwork approval and LC/deposit confirmation.
Our standard gravity transfusion sets are rated for gravity feed and standard pressure infusion bags up to 300 mmHg. For specialized volumetric or peristaltic infusion pumps, we manufacture dedicated high-elasticity pumping segment blood sets utilizing precision-extruded silicone or polyurethane tubing inserts that prevent wall tube fatigue and maintain linear volumetric accuracy throughout long pump infusion cycles.
Over 80% of Angiplast’s total production volume is exported across Latin America, Africa, the Middle East, Southeast Asia, CIS, and Europe.
Supplying institutional health authorities in Brazil, Colombia, Mexico, and Chile with Spanish/Portuguese pouch artwork, UDI barcoding, and ANVISA-oriented technical documentation.
Long-standing supplier to ministry health tenders in UAE, Saudi Arabia, Oman, and Iraq with GCC-standard registration dossiers and heat-sealed tropicalized protective packaging.
Supplying bulk-packed sterile blood sets for UNICEF, WHO tenders, and national health programs across Kenya, Nigeria, South Africa, Ghana, and Egypt.
High-capacity supply contracts with rapid sea-freight turnaround to Vietnam, Philippines, Indonesia, Malaysia, and Thailand.
CE-marked transfusion sets supporting importer registration requirements in Kazakhstan, Uzbekistan, and European distribution hubs.
Private label contract manufacturing for multinational medical device brand owners demanding validated Class 10,000 cleanroom production.
Connect directly with our engineering and export desk to request product catalogs, technical master files, sample kits, or tender quotation schedules.
